back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 08:45 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,108 vol |
20,175 | |
| Filed 2024-03-20 13:53 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,197
+1,435 vol $8.50 each |
17,067 | |
| Filed 2024-03-20 13:51 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,870 vol |
15,632 | |
| Filed 2024-03-20 13:48 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,491
+194 vol $7.69 each |
18,502 | |
| Filed 2024-03-20 13:45 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,347
+948 vol $7.75 each |
18,308 | |
| Filed 2023-04-04 16:09 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$26,002
+3,467 vol $7.50 each |
17,360 | |
| Filed 2023-04-04 16:08 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,382
+2,451 vol $7.50 each |
13,893 | |
| Filed 2023-04-04 16:07 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-36,765
-4,902 vol $7.50 each |
11,442 | |
| Filed 2023-03-13 16:53 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$410.64
+58 vol $7.08 each |
16,344 | |
| Filed 2023-03-13 16:48 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,495
+681 vol $8.07 each |
16,286 | |
| Filed 2022-04-05 10:05 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$23,997
+2,640 vol $9.09 each |
15,605 | |
| Filed 2022-03-31 12:33 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,989
+1,166 vol $7.71 each |
12,965 | |
| Filed 2021-03-23 12:28 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$20,301
+2,781 vol $7.30 each |
11,799 | |
| Filed 2021-03-12 13:50 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,952
+412 vol $4.74 each |
9,018 | |
| Filed 2020-04-02 11:39 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$17,501
+4,848 vol $3.61 each |
8,606 | |
| Filed 2020-03-31 15:52 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,697
+640 vol $7.34 each |
3,758 | |
| Filed 2020-03-31 15:48 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,118 | ||
| Filed 2019-03-28 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$15,371
+1,870 vol $8.22 each |
1,870 | |
| Filed 2019-03-28 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|